Wen Liu,Adam Robert Mezo,Francisco Alcides Valenzuela
申请号：
US16529095
公开号：
US20190345215A1
申请日:
2019.08.01
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The presently described compounds relate to the treatment of diabetes and/or hyperglycemia. More particularly, the described compounds relate to acylated insulin compounds that lower blood glucose, pharmaceutical compositions containing such compounds, therapeutic uses of such compounds, and an intermediate compound used to make the acylated insulin compounds.
